S
INSM icon

Sachetta’s Insmed INSM Stock Holding History

Sachetta’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960 Sell
9
-33
-79% -$4K ﹤0.01% 893
2026
Q1 		$6.87K Buy
42
+14
+50% +$2.15K ﹤0.01% 557
2025
Q4 		$4.87K Buy
28
+3
+12% +$547 ﹤0.01% 556
2025
Q3 		$3.6K Buy
+25
New +$3.06K ﹤0.01% 686

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Sachetta's INSM Position: Q2 2026 in Review

Sachetta reduced its Insmed (INSM) stake by 79% in Q2 2026, selling an estimated $4K and leaving 9 shares worth $960. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Sachetta first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.87K in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Sachetta held 9 shares of Insmed worth $960 as of Q2 2026.
  • Sachetta sold 33 Insmed shares in Q2 2026, an estimated $4K.
  • Insmed made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #893 holding.
  • Sachetta first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Sachetta's Insmed position peaked at $6.87K in Q1 2026.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.